Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery: a Randomized Trial

NCT07643792 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07643792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07643792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Surgery: a Randomized Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2028
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fascia iliaca block, hip surgery, liposomal bupivacaine, postoperative pain